Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer
- 15 April 1990
- journal article
- research article
- Published by Elsevier BV in Fibrinolysis
- Vol. 4 (2), 69-78
- https://doi.org/10.1016/0268-9499(90)90001-z
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A comparison of estimated proportional hazards models and regression treesStatistics in Medicine, 1989
- Correlation between urokinase‐type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomasInternational Journal of Cancer, 1988
- Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-betaThe Journal of cell biology, 1988
- Plasminogen activator content of gynecological tumors and their metastasesGynecologic Oncology, 1987
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986
- Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activityInternational Journal of Cancer, 1981
- Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7)Biochemical and Biophysical Research Communications, 1979
- Testing a Sequence of Observations for a Shift in LocationJournal of the American Statistical Association, 1977
- Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue cultureNature, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958